Is Artelo Biosciences, Inc. (ARTL) a Buy, Sell, or Hold?
NASDAQ : ARTL
Artelo Biosciences, Inc. — Competitors
$0.721 USD
-$0.03 (-4.17%)
- Volume
- 114.95K
- Average Volume
- 1.11M
- Market Capitalization
- $2.51M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $31.65
- Year Low
- $0.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.79
ARTL vs. The Competition
| Properties | ARTL | CARM | GTBP | LIPO |
|---|---|---|---|---|
| Market Cap | $2.51M | $104.61K | $10.1M | $152.49K |
| Shares Outstanding | $3.49M | $41.85M | $31.55M | $4.62M |
| P/E Ratio | -0.08 | 0.0 | -0.05 | -0.03 |
| EPS | -18.22 | 0.61 | -1.58 | -0.85 |
| Day Low | 0.721 | 0.0025 | 0.301 | 0.0327 |
| Day High | 0.721 | 0.0324 | 0.3275 | 0.058 |
| Year Low | 0.705 | 0.0001 | 0.261 | 0.02 |
| Year High | 31.65 | 0.556 | 1.78 | 0.641 |
| Average Price 50 | 1.12462 | 0.006279 | 0.4073 | 0.07282 |
| Average Price 200 | 4.01806 | 0.02736975 | 0.51817 | 0.17846 |
| Volume | 114.95K | 10296 | 568.21K | 160.09K |
| Average Volume | - | - | - | - |